We further show that FGF21-mediated autophagy induction and lowering lipids in obese mice are dependent on JMJD3 and that the hepatic FGF21-JMJD3-autophagy axis is likely dysregulated in NAFLD patients. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.